Sponsored by: Miller Legal LLP

Helping People Affected by Invega®

Contact Us:
(800) 846-1484(800) 846-1484

Invega Lawsuit

Invega Lawsuit

Invega (paliperidone) has been associated with potential side effects, particularly in adolescent males. If you or your son has been diagnosed with gynecomastia, the enlargement of male breast tissue, you may be eligible for financial compensation.

Our attorneys are currently investigating potential lawsuits on behalf of Invega users who have developed gynecomastia after being treated with the antipsychotic medication.

Gynecomastia is not life-threatening, but it can cause long-term emotional and psychological issues in males, especially in young men. Studies have shown that the condition can affect adolescent male’s self-esteem and mental health. Our lawyers believe that these side effects are unacceptable and that patients should be compensated for their suffering.

Find Out If You Have a Claim

If your son is battling the effects of this condition, we may be able to help you seek compensation for damages such as the cost of surgery and other treatments as well as emotional pain and suffering. To learn more, contact us today. Symptoms to watch out for include swelling of the breast tissue, breast tenderness and nipple discharge.

Invega® News

  • Study Shows Gynecomastia Affects the Psychological Well-Being of Adolescents

    April 29th, 2013

    According to a study published in the April issue of Plastic and Reconstructive Surgery, gynecomastia affects the psychological well-being of adolescent males, particularly in the areas of self-esteem, social functioning and mental health. Study authors ASPS Member Surgeon Dr. Brian I. Labow and colleagues from Boston Children's Hospital used data collected from surveys of 47 adolescent boys with gynecomastia and 92 healthy adolescent boys between... read more

  • Washington to Launch Awareness Program about Antipsychotic Drugs and Elderly Patients with Dementia

    April 25th, 2013

    A two-year grant from the Washington State Attorney General will allow the state of Washington's Long-Term Care Ombudsman Program (LTCOP) to launch a consumer awareness program about use of antipsychotic drugs in elderly people with dementia. According to Federal Way Mirror, the grant is funded by a settlement of a case against a division of Johnson & Johnson for the illegal marketing of the antipsychotic... read more